Precise genetic manipulation is essential for uncovering disease mechanisms, validating therapeutic targets, and creating accurate preclinical models.
I-Link Bio offers comprehensive gene editing services, including but not limited to iPSCs, using state-of-the-art CRISPR/Cas9 technology to generate targeted gene knockouts, knock-ins, and point mutations with high efficiency and reliability. In addition, we provide flexible approaches for gene overexpression or downregulation through plasmid DNA delivery, viral vectors, lipid nanoparticles (LNPs), and other optimized systems, ensuring the right method for each experimental need.
These services enable researchers to model patient-specific mutations, study gene function in disease-relevant cell types, and develop customized tools for drug discovery. Applications span from basic research and functional genomics to disease modeling, target validation, and preclinical development. By combining precision editing with our expertise in stem cell and differentiation platforms, we deliver high-quality, fully validated gene-edited lines that accelerate research and therapeutic innovation.